Alchemy Labs Inc. ALCLF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | ||
|---|---|---|---|---|---|
| Revenue | -25.07% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -25.07% | -- | -- | -- | |
| Cost of Revenue | -18.42% | -- | -- | -- | |
| Gross Profit | -52.71% | -- | -- | -- | |
| SG&A Expenses | 45.97% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -73.49% | -- | -- | -- | |
| Total Operating Expenses | 17.08% | -- | -- | -- | |
| Operating Income | -43.10% | -- | -- | -- | |
| Income Before Tax | -111.53% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -111.45% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -111.45% | -- | -- | -- | |
| EBIT | -43.10% | -- | -- | -- | |
| EBITDA | -42.99% | -- | -- | -- | |
| EPS Basic | -108.06% | -- | -- | -- | |
| Normalized Basic EPS | -108.10% | -- | -- | -- | |
| EPS Diluted | -103.83% | -- | -- | -- | |
| Normalized Diluted EPS | -108.10% | -- | -- | -- | |
| Average Basic Shares Outstanding | 1.95% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 1.95% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |